Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113255884 | 11325588 | 4 | F | 20141222 | 20160812 | 20150731 | 20160816 | EXP | CA-ROCHE-1615622 | ROCHE | 64.31 | YR | M | Y | 0.00000 | 20160816 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113255884 | 11325588 | 1 | PS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | 300 MG, BIW (EVERY 2 WEEKS) | U | S0062 | 103976 | 300 | MG | SOLUTION FOR INJECTION | QOW | ||||
| 113255884 | 11325588 | 2 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0062 | 103976 | SOLUTION FOR INJECTION | |||||||
| 113255884 | 11325588 | 3 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Unknown | U | 0 | ||||||||||
| 113255884 | 11325588 | 4 | C | UNIPHYL | THEOPHYLLINE ANHYDROUS | 1 | Unknown | U | 0 | ||||||||||
| 113255884 | 11325588 | 5 | C | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | U | 0 | ||||||||||
| 113255884 | 11325588 | 6 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Unknown | U | 0 | ||||||||||
| 113255884 | 11325588 | 7 | C | AVAMYS | FLUTICASONE FUROATE | 1 | Unknown | U | 0 | ||||||||||
| 113255884 | 11325588 | 8 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Unknown | U | 0 | ||||||||||
| 113255884 | 11325588 | 9 | C | ACETYLSALICYLIC ACID | ASPIRIN | 1 | Unknown | U | 0 | ||||||||||
| 113255884 | 11325588 | 10 | C | COVERSYL | PERINDOPRIL | 1 | Unknown | U | 0 | ||||||||||
| 113255884 | 11325588 | 11 | C | PERINDOPRIL | PERINDOPRIL | 1 | Unknown | U | 0 | ||||||||||
| 113255884 | 11325588 | 12 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 113255884 | 11325588 | 1 | Asthma |
| 113255884 | 11325588 | 3 | Product used for unknown indication |
| 113255884 | 11325588 | 4 | Product used for unknown indication |
| 113255884 | 11325588 | 5 | Product used for unknown indication |
| 113255884 | 11325588 | 6 | Product used for unknown indication |
| 113255884 | 11325588 | 7 | Product used for unknown indication |
| 113255884 | 11325588 | 8 | Product used for unknown indication |
| 113255884 | 11325588 | 9 | Product used for unknown indication |
| 113255884 | 11325588 | 10 | Product used for unknown indication |
| 113255884 | 11325588 | 11 | Product used for unknown indication |
| 113255884 | 11325588 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 113255884 | 11325588 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 113255884 | 11325588 | Asthma | |
| 113255884 | 11325588 | Blood pressure fluctuation | |
| 113255884 | 11325588 | Blood pressure increased | |
| 113255884 | 11325588 | Contusion | |
| 113255884 | 11325588 | Cough | |
| 113255884 | 11325588 | Fatigue | |
| 113255884 | 11325588 | Influenza | |
| 113255884 | 11325588 | Lung infection | |
| 113255884 | 11325588 | Nasopharyngitis | |
| 113255884 | 11325588 | Peripheral swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 113255884 | 11325588 | 1 | 20140815 | 0 | ||
| 113255884 | 11325588 | 2 | 20160601 | 0 |